Items · Publications of University of Banja Luka

Did you win hepatitis C? (2017)

A. Verhaz, Did you win hepatitis C?, 2017

Interferon free terapija u liječenju oboljelih od hroničnog hepatitisa c - naša iskustva (2017-10)

A. Verhaz, Interferon free terapija u liječenju oboljelih od hroničnog hepatitisa c - naša iskustva, Zbornik radova IV kongres infektologa sa međunarodnim učešćem, pp. 8 - 9, Oct, 2017

Efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir treatment of hepatitis C patients in Republic of Srpska (2017-11)

A. Verhaz, Efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir treatment of hepatitis C patients in Republic of Srpska, pp. 23 - 24, Nov, 2017

Aktuelne virusne infekcije, Trebinje,Simpozijum aktuelne virusne infekcije (2018-05)

A. Verhaz, Aktuelne virusne infekcije, Trebinje,Simpozijum aktuelne virusne infekcije, Savremeni pristup lijecenju hronicnih hepatitisa C u Republici Srpskoj, May, 2018

Efficasy and safety of ombitasvir/peritaprevir/ritonavir+ dasabuvir+ ribavirin in patients treated at the Clinic for infectious diseases, republica Srpska Banja Luka (2018-09)

A. Verhaz, Efficasy and safety of ombitasvir/peritaprevir/ritonavir+ dasabuvir+ ribavirin in patients treated at the Clinic for infectious diseases, republica Srpska Banja Luka, Sep, 2018

Novosti u dijagnostici i liječenju Hepatitisa C (2018-09)

A. Verhaz, Novosti u dijagnostici i liječenju Hepatitisa C, Sep, 2018

KOMPLIKACIJE VARIČELA U KLINICI ZA INFEKTIVNE BOLESTI UKC RS U ŠESTOGODIŠNJEM PERIODU 2012. – 2017. GODINE (2018-09)

A. Verhaz, O. Jović-Đokanović, KOMPLIKACIJE VARIČELA U KLINICI ZA INFEKTIVNE BOLESTI UKC RS U ŠESTOGODIŠNJEM PERIODU 2012. – 2017. GODINE, Sep, 2018

Rates of pregnancy and preterm birth in Central/Eastern Europe and neighboring countries – data from ECEE Networg Group (2018-09)

A. Verhaz, J. Kowalska, Rates of pregnancy and preterm birth in Central/Eastern Europe and neighboring countries – data from ECEE Networg Group, Sep, 2018

EFFICACY AND SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR REGIMEN IN PATIENTS WITH SEVERE RENAL IMPAIRMENT WITH HCV GENOTYPE 1B INFECTION – CASE REPORT (2018-09)

A. Verhaz, T. Roganović, T. Macanović-Kostić, EFFICACY AND SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR REGIMEN IN PATIENTS WITH SEVERE RENAL IMPAIRMENT WITH HCV GENOTYPE 1B INFECTION – CASE REPORT, Sep, 2018

DISTRIBUCIJA GENOTIPOVA HEPATITIS C VIRUSA U REPUBLICI SRPSKOJ: DESETOGODIŠNJE RETROSPEKTIVNO ISKUSTVO (2019-09)

A. Verhaz, DISTRIBUCIJA GENOTIPOVA HEPATITIS C VIRUSA U REPUBLICI SRPSKOJ: DESETOGODIŠNJE RETROSPEKTIVNO ISKUSTVO, Acta Med Sal 2019;49-Supplement 1: S1-S262, pp. 68 - 69, Sep, 2019

Suvremeni pristup liječenju kroničnog hepatitisa C u Republici Srpskoj / Contemporary approach to the treatment of chronic hepatitis C in Republic of Srpska (2019-10)

A. Verhaz, Z. Vuković, T. Macanović Kostić, Suvremeni pristup liječenju kroničnog hepatitisa C u Republici Srpskoj / Contemporary approach to the treatment of chronic hepatitis C in Republic of Srpska, Oct, 2019

Where are we with PrEP use in Central and Eastern Europe? – data from the ECEE Network Group (2019-11)

J. Begovac, A. Skrzat-Klapaczyńska, J. Kowalska, A. Verhaz, Where are we with PrEP use in Central and Eastern Europe? – data from the ECEE Network Group, EACS Conference 2019 Abstract Nr PE28/15, Nov, 2019

Viral hepatitis in HIV-positive patients – testing, prophylaxis and treatment in Central and Eastern Europe (2019-11)

K. Kase, A. Skrzat-Klapaczyńska, J. Kowalska, A. Verhaz, Viral hepatitis in HIV-positive patients – testing, prophylaxis and treatment in Central and Eastern Europe, EACS Conference 2019 Abstract Nr PE31/11, Nov, 2019

Regional Consultation for Developing Global Health Sector Strategies on HIV, Viral Hepatitis and STIs, 2022–2030 (2021-06)

A. Verhaz, Regional Consultation for Developing Global Health Sector Strategies on HIV, Viral Hepatitis and STIs, 2022–2030, Jun, 2021

Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2021-10)

J. Kowalska, D. Bursa, D. Jilich, S. Antonjak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, A. Verhaz, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, ePoster. PE4/18ecee.president@gmail.com, Oct, 2021

Protokoli za dijagnozu i menadžment suspektnih i potvrđenih slučajeva COVID-19, primjena odgovarajućih javnozdravstvenih mjera i terapijski protokoli i nje (2022)

A. Verhaz, Protokoli za dijagnozu i menadžment suspektnih i potvrđenih slučajeva COVID-19, primjena odgovarajućih javnozdravstvenih mjera i terapijski protokoli i nje, 2022

Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)

J. Kowalska, C. Bieńkowski, L. Fleischhans, S. Antonjak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Goengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, . Horban, Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group, Nov, 2022

HIV Disease Metrics and COVID-19 infection severity and outcomes in People Living with HIV in Central and Eastern Europe (2023)

A. Verhaz, HIV Disease Metrics and COVID-19 infection severity and outcomes in People Living with HIV in Central and Eastern Europe, 2023

Optimizacija tretmana hepatocelularnog i karcinoma dojke (2023-03)

A. Verhaz, Optimizacija tretmana hepatocelularnog i karcinoma dojke, Pozvano predavanje Hepatocelulrni karcinom i virusni hepatitisi, Mar, 2023

Učestalost oksigenacionih poremećaja u cirozi jetre (2016-05)

Z. Mavija, M. Mavija, S. Grbić, A. Verhaz, M. Vučić, Učestalost oksigenacionih poremećaja u cirozi jetre, ČASOPIS UDRUŽENJA PULMOLOGA REPUBLIKE SRPSKE, Vol. 6, No. 1-2, pp. 91 - 96, May, 2016